Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

Bath & Body Works (NYSE:BBWI - Get Rating) had its target price cut by Barclays from $59.00 to $53.00 in a research note issued to investors on Friday, The Fly reports. Barclays's price objective suggests a potential upside of 10.88% from the company's current price.

A number of other equities analysts also recently commented on BBWI. Citigroup reduced their target price on shares of Bath & Body Works from $100.00 to $93.00 and set a "buy" rating on the stock in a research note on Friday, January 7th. Credit Suisse Group reduced their target price on shares of Bath & Body Works from $69.00 to $64.00 and set a "neutral" rating on the stock in a research note on Friday, February 25th. Morgan Stanley lifted their target price on shares of Bath & Body Works from $90.00 to $95.00 and gave the stock an "overweight" rating in a research note on Friday, February 25th. JPMorgan Chase & Co. reduced their target price on shares of Bath & Body Works from $105.00 to $81.00 and set an "overweight" rating on the stock in a research note on Thursday, February 24th. Finally, BMO Capital Markets dropped their price target on shares of Bath & Body Works from $90.00 to $83.00 and set an "outperform" rating for the company in a research report on Thursday, February 24th. Three analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus price target of $79.72.

NYSE:BBWI opened at $47.80 on Friday. The company's 50-day moving average price is $52.26 and its 200-day moving average price is $62.84. The company has a market cap of $11.42 billion, a P/E ratio of 9.72, a P/E/G ratio of 1.17 and a beta of 1.80. Bath & Body Works has a twelve month low of $45.46 and a twelve month high of $82.00.

Bath & Body Works (NYSE:BBWI - Get Rating) last posted its quarterly earnings results on Tuesday, February 22nd. The company reported $2.30 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $2.27 by $0.03. The firm had revenue of $3.03 billion for the quarter, compared to the consensus estimate of $2.96 billion. Bath & Body Works had a net margin of 14.13% and a negative return on equity of 115.32%. The company's revenue for the quarter was up 11.4% on a year-over-year basis. During the same period last year, the firm posted $1.96 earnings per share. As a group, analysts expect that Bath & Body Works will post 4.59 earnings per share for the current year.

A number of hedge funds and other institutional investors have recently bought and sold shares of BBWI. EWG Elevate Inc. lifted its position in shares of Bath & Body Works by 2.2% during the 4th quarter. EWG Elevate Inc. now owns 11,491 shares of the company's stock worth $802,000 after buying an additional 246 shares during the last quarter. Signaturefd LLC lifted its position in shares of Bath & Body Works by 72.4% during the 4th quarter. Signaturefd LLC now owns 693 shares of the company's stock worth $48,000 after buying an additional 291 shares during the last quarter. Profund Advisors LLC lifted its position in shares of Bath & Body Works by 5.6% during the 4th quarter. Profund Advisors LLC now owns 5,676 shares of the company's stock worth $396,000 after buying an additional 300 shares during the last quarter. GM Advisory Group Inc. lifted its position in shares of Bath & Body Works by 0.5% during the 4th quarter. GM Advisory Group Inc. now owns 71,120 shares of the company's stock worth $4,963,000 after buying an additional 350 shares during the last quarter. Finally, Acadian Asset Management LLC purchased a new stake in shares of Bath & Body Works during the 4th quarter worth approximately $30,000. Institutional investors own 92.23% of the company's stock.

Bath & Body Works Company Profile (Get Rating)

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. The company sells its products under the Bath & Body Works, White Barn, and other brand names through specialty retail stores and websites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.

Featured ArticlesGet a free copy of the StockNews.com research report on Bath & Body Works (BBWI)Should You Take a Shot on Sportsman’s Warehouse?Thar's Gold in Them Thar Hills: 3 Best Mining Stocks Right Now4 Best Grocery Store Stocks to Add to Your Portfolio in April 2022PVH Corp Stock May Be Turning Around High-Yielding Walgreens Boots Alliance Goes On Sale

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Before you consider Bath & Body Works, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.

While Bath & Body Works currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:

Each market day you'll get a one-minute market summary to help you invest wisely.

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved. 326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257 MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.